Systemically administered interleukin-1 (IL-1) has been shown to preferentially bind to IL-1 receptors (IL-1Rs) in inflammation. Using radiolabeled IL-1a and molecular methods to assess gene expression for these receptors, the in vivo behavior of these receptors was investigated in a number of experimental inflammatory conditions. The uptake of 125 I-labeled IL-1a in inflammatory foci significantly correlated with the mRNA expression for the type I and type II IL-1Rs (P õ .05). Type II IL-1R mRNA showed a greater increase in expression than type I IL-1R mRNA. In neutropenic mice, inflammatory lesions, which are devoid of granulocytes, significantly lower 125 Ilabeled IL-1a uptake (P õ .001), and type II IL-1R mRNA expression (P õ .005) was found. Thus, there is strong up-regulation of IL-1Rs at sites of focal inflammation. Of interest, this mainly involved the type II IL-1R on granulocytes, which is not involved in signal transduction. 50 mL of TE. The RNA solution was treated with 10 U of DNase All animal studies undertaken as part of the research from which this manu-I by heating for 50 min at 37ЊC followed by heating for 5 min at script was derived are in compliance with regulations of our institutions and with generally accepted guidelines governing such work.
Interleukin-1 receptors (IL-1Rs) mediate the biologic effects mol/L, as determined on the murine cell line EL-4-6.1 [3] .
of IL-1. The type I receptor leads to signal transduction, and
In vivo biodistribution studies. Focal infections were induced the type II receptor acts as a decoy receptor [1] . The distribution with 2 1 10 7 cfu of Staphylococcus aureus, 2.5 1 10 6 cfu of of these receptors during the steady state has been well studied Escherichia coli, or 10 7 cfu of Candida albicans in 0.05 mL of a [2] . However, little information is available on the expression 50%-50% suspension of autologous blood and normal saline or of IL-1Rs during inflammation.
100% saline (C. albicans) injected into the left calf muscles of
We have previously demonstrated that exogenously adminisether-anesthetized normal and neutropenic female Swiss mice (20-tered IL-1 localizes in inflammatory foci by virtue of binding 25 g; n Å 25/group) [3] . Neutropenia was induced as previously to receptors [3, 4] , the type II receptor being the predominant described [4] . Analogously, sterile inflammations were induced by binding site [4] . To further investigate the in vivo behavior of intramuscular injection of 0.05 mL of turpentine (n Å 25) or 0.05 mL of 7.5% zymosan in sterile saline (n Å 25). Twenty-four hours IL-1Rs, the retention of radiolabeled IL-1a in a variety of after the induction of inflammation, when swelling of the muscle inflammatory models was studied in normal and neutropenic was apparent, mice were injected with 0. acterized by significantly reduced leukocytic infiltration as Total RNA (1 mg) was reverse-transcribed as previously de- compared to inflammatory tissue of immunocompetent mice scribed [7] . PCR amplification of GAPDH cDNA and IL-1R cDNA (data not shown).
was done in 22 and 32 successive cycles, respectively. Preceding
Expression of type I and type II IL-1R mRNA in various
the PCR amplification, the cDNA was denatured for 5 min at 92ЊC.
inflammations. As summarized in table 1, both type I (except After PCR amplification, the cDNA was extended for 10 min at 72ЊC. PCR products were analyzed as described [7] . I-labeled IL-1a was retained in all inflammatory foci during the time IL-1a tissue uptake correlated significantly with the expression course of the study. After 6 h after injection, tissue biodistribuof type I and type II IL-1R mRNAs with correlation coefficients tion showed highest uptake levels in the inflammatory foci.
(r 2 ) of 0.69 and 0.71, respectively, both significantly different Despite similar behavior of 125 I-labeled IL-1a in the various from zero (P õ .05, linear regression analysis). models, the degree of uptake of 125 I-labeled IL-1a in the various types of inflammation was different (table 1) . Nevertheless, Discussion compared with noninflamed muscle, significantly higher uptake levels were found in all types of inflammation (P õ .001, The in vivo behavior and localization of systemically administered IL-1 in various types of inflammation in mice was ANOVA). Furthermore, the uptake of 125 I-labeled IL-1a in studied and correlated with the expression of both type I and To our knowledge, this is the first report on the in vivo expression of type I and type II IL-1R mRNA in inflammatory tissue. type II IL-1R mRNAs at the inflammatory site. Radiolabeled IL-1 preferentially localized in various infectious and inflam-
The mRNA levels were determined by RT-PCR, a very powerful technique by which to detect even low mRNA levels, which has matory lesions to a degree that correlated with the gene expression of the IL-1Rs. All inflammatory tissues showed increased also been used by other investigators to determine murine type I and type II IL-1R mRNA expression on both cell lines [6] and type I and type II IL-1R mRNA expression, with greater upregulation of type II IL-1R mRNA. The importance of the type in normal tissue [12] . Despite the many advantages of RT-PCR, the variability of gene amplification often compromises the quanti-II IL-1R for IL-1 uptake in inflammation was shown in studies with neutropenic mice. Lesions in these mice were charactertative use of the method. For this purpose, internal standards as endogenous control genes are required, such as GAPDH [13], ized by reduced leukocytic infiltration and showed lower IL-1 uptake and type II IL-1R mRNA expression than in inflammawhich has been used in our studies. tory lesions in normal mice.
We found a good correlation between IL-1a uptake and the In previous IL-1R blockade studies, we demonstrated that expression of IL-1R mRNA in the various inflammatory lesions systemically administered IL-1 binds mainly to type II ILstudied. However, it should be kept in mind that we detected 1Rs in inflammation [4] . This finding is corroborated in the receptor mRNA and not protein, and of course not all mRNA observations in the present study: Inflammatory lesions in neuwill be translated into receptor proteins. In addition, other factors tropenic mice showed significantly lower IL-1 uptake than analbesides degree of expression of the target receptor might deterogous lesions in normal mice, with similar type I but signifimine the in vivo localization of a systemically administered procantly higher type II mRNA expression. Furthermore, elevated tein in affected tissue. Jain et al. [14] reported several of such expression of type II IL-1Rs was found in all inflammatory factors in tumor, which may also hold true for inflammation, tissues studied. The increased mRNA expression of type II ILincluding heterogenous blood supply, different transport distances 1R is most probably related to the presence of locally infiltrated in the interstitium, and varying interstitial pressures. leukocytes, predominantly polymorphonuclear cells, in the
The question remains what the biologic significance is of models used. These cells exclusively express type II IL-1Rs the up-regulation of in particular the type II IL-1R, since this [8] . This is supported by our finding that inflammation in neureceptor, in contrast to the type I IL-1R, is not mediating signal tropenic mice, characterized by reduced leukocytic infiltration, transduction but is acting as a decoy receptor [15] . It might showed significantly less type II IL-1R mRNA than did similar be that this up-regulation should be viewed as a protective tissue in normal mice. In noninflamed muscular tissue, type I mechanism against cytokine damage and as part of the antiin-IL-1R mRNA expression was significantly higher than of type flammatory response that occurs during infection. II IL-1R mRNA, most likely reflecting the preponderance of type I IL-1R on various cells in normal muscular tissue as
